First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform
Go back to First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform| (NASDAQ: CABA) | Delayed: 3.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.01 | 52 Week High | $ | |||
| Open | $3.01 | 52 Week Low | $ | |||
| Day High | $3.01 | P/E | N/A | |||
| Day Low | $3.01 | EPS | $ | |||
| Volume | 2,613 | |||||
